The natriuretic peptide family consists of three biologically active peptides: atrial natriuretic
peptide (ANP), brain (or B-type) natriuretic peptide (BNP), and C-type natriuretic peptide …

Cardiac biomarkers are integral to the diagnosis and the treatment of acutely ill cardiac
patients. The Working Group on Acute Cardiac Care of the European Society of Cardiology …

The mammalian natriuretic peptide family consists of atrial (ANP), brain [B-type; BNP] and C-
type natriuretic peptide (CNP) and three receptors, natriuretic receptors-A (NPR-A),-B (NPR …

Background—B-type natriuretic peptide (BNP) has been associated with short-and long-
term postdischarge prognosis among hospitalized patients with heart failure. It is unknown if …

BACKGROUND: To prospectively determine the prognostic utility of serial sampling of the
interleukin-1 receptor family member, ST2, for predicting 90-day mortality in patients with …

The last decade has seen exciting advances in the field of biomarkers used in managing
patients with heart failure (HF). Biomarker research has broadened our knowledge base …

Brain natriuretic peptide (BNP) is an important biomarker for patients with heart failure,
hypertension and cardiac hypertrophy. Although it is known that BNP levels are relatively …

We examined the effect of renal dysfunction on B-natriuretic peptide (BNP), N-terminal (NT)-
proBNP, and their molar ratio at varying severities of cardiac function in 94 Thai patients with …

Aims The aim of this study was to evaluate the prognostic utility of small troponin I (TnI)
elevations, serial TnI measurements, and the combination of TnI and brain natriuretic …

Among the three natriuretic peptides, atrial/A-type natriuretic peptide (ANP) and brain/B-type
natriuretic peptide (BNP) are primarily produced by, and secreted from, heart tissue. They …